DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Mahon FX, Rea D, Guilhot J. et al.
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: The prospective, multicentre stop imatinib (STIM) trial.

Lancet Oncol 2010;
11: 1029-1035

Download Bibliographical Data

Access:
Access:
Access: